Synthesis and Initial In Vivo Evaluation of [11C]AZ683-A Novel PET Radiotracer for Colony Stimulating Factor 1 Receptor (CSF1R).
Sean S TanzeyXia ShaoJenelle StauffJanna ArteagaPhillip ShermanPeter J H ScottAndrew V MossinePublished in: Pharmaceuticals (Basel, Switzerland) (2018)
Positron emission tomography (PET) imaging of Colony Stimulating Factor 1 Receptor (CSF1R) is a new strategy for quantifying both neuroinflammation and inflammation in the periphery since CSF1R is expressed on microglia and macrophages. AZ683 has high affinity for CSF1R (Ki = 8 nM; IC50 = 6 nM) and >250-fold selectivity over 95 other kinases. In this paper, we report the radiosynthesis of [11C]AZ683 and initial evaluation of its use in CSF1R PET. [11C]AZ683 was synthesized by 11C-methylation of the desmethyl precursor with [11C]MeOTf in 3.0% non-corrected activity yield (based upon [11C]MeOTf), >99% radiochemical purity and high molar activity. Preliminary PET imaging with [11C]AZ683 revealed low brain uptake in rodents and nonhuman primates, suggesting that imaging neuroinflammation could be challenging but that the radiopharmaceutical could still be useful for peripheral imaging of inflammation.
Keyphrases
- pet imaging
- positron emission tomography
- computed tomography
- oxidative stress
- high resolution
- traumatic brain injury
- pet ct
- cerebrospinal fluid
- lipopolysaccharide induced
- photodynamic therapy
- inflammatory response
- cognitive impairment
- dna methylation
- squamous cell carcinoma
- spinal cord injury
- multiple sclerosis
- resting state
- white matter
- mass spectrometry
- blood brain barrier
- single cell
- functional connectivity
- neoadjuvant chemotherapy
- neuropathic pain
- brain injury
- chemotherapy induced